In gliomas, PLBD1 was expressed to a significantly higher extent in GBM than in LGG, and the expression of PLBD1 was higher in patients with IDH mutations than in patients with IDH wild-type, which is thought to be the key to better prognosis 32. This evidence concerns the gene PLBD1 and glioblastoma.